ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Alhemo 150 mg/1.5 ml, Injektionslösung im Fertigpen - 
68844003 Novo Nordisk Pharma AG
Alhemo 150 mg/1.5 ml, Injektionslösung im Fertigpen08.08.2023
  08.08.2023
Concizumab (B02BX10) 
WHO-DDD07.08.2028
06.01.10. 
06.01.10. 
A  
Yes 
IP 
10558.20Yes
    
10 %10873.75
  
7680688440034Biotechnologika
  
Composition
concizumabum 100 mg, histidinum, arginini hydrochloridum, natrii chloridum, saccharum, polysorbatum 80, phenolum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.0 ml corresp. natrium max. 0.0362 mmol.
Packungsbestandteile
Injektionslösung im Fertigpen 
  
 
Active AgentDose
Concizumabum100mg / 1ml
BAG: Active AgentDose
Concizumabum150 mg
 
Inactive agents
Acidum Hydrochloridum ad Ph
Arginine Hydrochloride
Histidine
Sodium Chloride
Natrii Hydroxidum ad Ph
Phenol
Polysorbatum 80
Saccharum
 
Source
Data was imported : 08.11.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home